LONDON, May 15, 2017 /PRNewswire/ -- Since the introduction of generic drugs in 2001, Brazil's pharmaceutical industry has undergone a transformation.
Generic drugs have been continuously gaining market share and currently account for a significant share of the total pharmaceutical market in Brazil. According to estimates, around BRL 2 Billion worth of branded drugs are expected to lose patent protection during the next five years.
Here are some key factors of the study:
- The high potential of generic drugs is also driven by the fact that despite strong growth in recent years, the penetration of generics still remains low compared to mature markets such as Germany, the United States, the United Kingdom, etc.
- These factors along with a rising ageing population, increasing prevalence of life style diseases and the significant cost savings achieved from the use of generic drugs are expected to drive this market during the next five years.
This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the market for generic drugs in Brazil.
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/brl-2-billion-worth-of-branded-drugs-forecast-to-lose-patent-protection-in-five-years-300457811.html